2009). Furthermore, several studies have indicated a protective role for IL-10 in obesity-induced metabolic dysregulation, with evidence that concentrations are reduced in patients with insulin resistance and type 2 diabetes (van Exel et al. 2007; Lumeng et al. 1993). The gene discussed is IL10; the disease is obesity due to melanocortin 4 receptor deficiency.